Over‐the‐Counter Epinephrine for Asthma Treatment: Too Much Risk for Too Little Benefit
Crossref DOI link: https://doi.org/10.1002/jcph.2146
Published Online: 2022-10-03
Published Print: 2022-12
Update policy: https://doi.org/10.1002/crossmark_policy
Gaynes, Bruce I.
,
Version of Record valid from 2022-10-03
Publication History
Received: 2022-08-22
Accepted: 2022-08-25
Published: 2022-10-03
